Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
Argus Health
Harvard Business School
Julphar
Mallinckrodt
Moodys
Queensland Health
Fuji
Accenture

Generated: August 16, 2017

DrugPatentWatch Database Preview

FREAMINE III 8.5% W/ ELECTROLYTES Drug Profile

« Back to Dashboard

Which patents cover Freamine Iii 8.5% W/ Electrolytes, and what generic Freamine Iii 8.5% W/ Electrolytes alternatives are available?

Freamine Iii 8.5% W/ Electrolytes is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in FREAMINE III 8.5% W/ ELECTROLYTES is amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate. There are three hundred and thirty-nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate profile page.

Summary for Tradename: FREAMINE III 8.5% W/ ELECTROLYTES

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list1
Clinical Trials: see list11,214
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:FREAMINE III 8.5% W/ ELECTROLYTES at DailyMed

Pharmacology for Tradename: FREAMINE III 8.5% W/ ELECTROLYTES

Ingredient-typeAmino Acids
Drug ClassAmino Acid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun
FREAMINE III 8.5% W/ ELECTROLYTES
amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate
INJECTABLE;INJECTION016822-007Jul 1, 1988RXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
Cantor Fitzgerald
Daiichi Sankyo
Farmers Insurance
QuintilesIMS
Julphar
Fuji
Deloitte
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot